These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 22335555)
1. 1,2,3,4-tetrahydroquinoline-based selective human neuronal nitric oxide synthase (nNOS) inhibitors: lead optimization studies resulting in the identification of N-(1-(2-(methylamino)ethyl)-1,2,3,4-tetrahydroquinolin-6-yl)thiophene-2-carboximidamide as a preclinical development candidate. Ramnauth J; Renton P; Dove P; Annedi SC; Speed J; Silverman S; Mladenova G; Maddaford SP; Zinghini S; Rakhit S; Andrews J; Lee DK; Zhang D; Porreca F J Med Chem; 2012 Mar; 55(6):2882-93. PubMed ID: 22335555 [TBL] [Abstract][Full Text] [Related]
2. Discovery of cis-N-(1-(4-(methylamino)cyclohexyl)indolin-6-yl)thiophene-2-carboximidamide: a 1,6-disubstituted indoline derivative as a highly selective inhibitor of human neuronal nitric oxide synthase (nNOS) without any cardiovascular liabilities. Annedi SC; Ramnauth J; Maddaford SP; Renton P; Rakhit S; Mladenova G; Dove P; Silverman S; Andrews JS; Felice MD; Porreca F J Med Chem; 2012 Jan; 55(2):943-55. PubMed ID: 22175766 [TBL] [Abstract][Full Text] [Related]
3. Discovery of a potent, orally bioavailable and highly selective human neuronal nitric oxide synthase (nNOS) inhibitor, N-(1-(piperidin-4-yl)indolin-5-yl)thiophene-2-carboximidamide as a pre-clinical development candidate for the treatment of migraine. Annedi SC; Maddaford SP; Ramnauth J; Renton P; Rybak T; Silverman S; Rakhit S; Mladenova G; Dove P; Andrews JS; Zhang D; Porreca F Eur J Med Chem; 2012 Sep; 55():94-107. PubMed ID: 22840695 [TBL] [Abstract][Full Text] [Related]
4. First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain. Mladenova G; Annedi SC; Ramnauth J; Maddaford SP; Rakhit S; Andrews JS; Zhang D; Porreca F J Med Chem; 2012 Apr; 55(7):3488-501. PubMed ID: 22420844 [TBL] [Abstract][Full Text] [Related]
5. Discovery of N-(3-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indol-6-yl) thiophene-2-carboximidamide as a selective inhibitor of human neuronal nitric oxide synthase (nNOS) for the treatment of pain. Annedi SC; Maddaford SP; Mladenova G; Ramnauth J; Rakhit S; Andrews JS; Lee DK; Zhang D; Porreca F; Bunton D; Christie L J Med Chem; 2011 Oct; 54(20):7408-16. PubMed ID: 21923116 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluation of 3,4-dihydroquinolin-2(1H)-one and 1,2,3,4-tetrahydroquinoline-based selective human neuronal nitric oxide synthase (nNOS) inhibitors. Ramnauth J; Speed J; Maddaford SP; Dove P; Annedi SC; Renton P; Rakhit S; Andrews J; Silverman S; Mladenova G; Zinghini S; Nair S; Catalano C; Lee DK; De Felice M; Porreca F J Med Chem; 2011 Aug; 54(15):5562-75. PubMed ID: 21699209 [TBL] [Abstract][Full Text] [Related]
7. Discovery of dual inducible/neuronal nitric oxide synthase (iNOS/nNOS) inhibitor development candidate 4-((2-cyclobutyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1H)-one (KD7332) part 2: identification of a novel, potent, and selective series of benzimidazole-quinolinone iNOS/nNOS dimerization inhibitors that are orally active in pain models. Payne JE; Bonnefous C; Symons KT; Nguyen PM; Sablad M; Rozenkrants N; Zhang Y; Wang L; Yazdani N; Shiau AK; Noble SA; Rix P; Rao TS; Hassig CA; Smith ND J Med Chem; 2010 Nov; 53(21):7739-55. PubMed ID: 20931971 [TBL] [Abstract][Full Text] [Related]
8. Novel, druglike 1,7-disubstituted 2,3,4,5-tetrahydro-1H-benzo[b]azepine-based selective inhibitors of human neuronal nitric oxide synthase (nNOS). Annedi SC; Ramnauth J; Cossette M; Maddaford SP; Dove P; Rakhit S; Andrews JS; Porreca F Bioorg Med Chem Lett; 2012 Apr; 22(7):2510-3. PubMed ID: 22370270 [TBL] [Abstract][Full Text] [Related]
9. Potent and selective double-headed thiophene-2-carboximidamide inhibitors of neuronal nitric oxide synthase for the treatment of melanoma. Huang H; Li H; Yang S; Chreifi G; Martásek P; Roman LJ; Meyskens FL; Poulos TL; Silverman RB J Med Chem; 2014 Feb; 57(3):686-700. PubMed ID: 24447275 [TBL] [Abstract][Full Text] [Related]
10. Discovery and optimization of 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives as a novel class of selective cannabinoid CB2 receptor agonists. van der Stelt M; Cals J; Broeders-Josten S; Cottney J; van der Doelen AA; Hermkens M; de Kimpe V; King A; Klomp J; Oosterom J; Pols-de Rooij I; de Roos J; van Tilborg M; Boyce S; Baker J J Med Chem; 2011 Oct; 54(20):7350-62. PubMed ID: 21923175 [TBL] [Abstract][Full Text] [Related]